The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1356
January 24, 2011
View Complete Issue         Table of Contents 2019 
Botulinum Toxin for Chronic Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Botulinum Toxin for Chronic Migraine
January 24, 2011 (Issue: 1356)
The FDA has approved injection of onabotulinumtoxinA (Botox – Allergan) for prevention of headaches in adult patients with chronic migraine (≥15 headache days/month for ≥3 months). It is the first drug approved for treatment of this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Botulinum Toxin for Chronic Migraine
Article code: 1356b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.